Skip to content

Screening for Cognitive Disorders in Multiple Sclerosis

Screening for Cognitive Disorders in Multiple Sclerosis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07030036
Enrollment
60
Registered
2025-06-19
Start date
2025-07-15
Completion date
2025-11-15
Last updated
2025-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Dysfunction, Multiple Sclerosis, Neuropsychological Tests, Quality of Life

Brief summary

This study aims to identify cognitive problems in adults with multiple sclerosis (MS). MS can affect memory, thinking speed, and spatial skills, which may impact daily life and work. We will use simple and proven tests to check for these difficulties and see how they affect quality of life. The study will include about 60 patients followed at the neurology day hospital.

Interventions

None listed

Sponsors

Centre Hospitalier de Gonesse
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients aged 18 years or older * Diagnosed with multiple sclerosis (MS) for at least 6 months according to the 2017 McDonald criteria (SFSEP) * Receiving disease-modifying treatment and followed in the neurology day hospital of CH Gonesse

Exclusion criteria

\- Under 18 years old

Design outcomes

Primary

MeasureTime frame
Prevalence of cognitive impairment in patients with multiple sclerosis, assessed by validated cognitive tests (CSCT, RL/RI-16, Figure de REY, HAD scale, SF-12).12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026